medigraphic.com
ISSN 0016-3813 (Print)

2003, Number 5

Next >>

Gac Med Mex 2003; 139 (5)

Liver Enzyme Modification in Undernourished Rats Treated with Acetaminophen

González-Mendoza M, Vicuña-Fernández N

Language: Spanish
References: 29
Page: 429-433
PDF size: 55.33 Kb.


ABSTRACT

Acetaminophen is used as an analgesic and antipyretic. Due to its relative safety at therapeutic dose, it is frequently used in children and in pregnant women. We evaluated the effect of a dose equivalent to the therapeutic dose of Acetaminophen in undernourished rats; 72 Wistar male rats of 18 weeks of age, with weight between 270 and 280 g, were distributed randomly in four groups: A, normal without food restriction; B, normal without food restriction treated with Acetaminophen (100mg/kg); C; undernourished by food restriction and D, undernourished by food restriction treated with Acetaminophen (100mg/kg). The results showed decreasing of body and hepatic weight in undernourished rats and in undernourished treated with Acetaminophen, significant decrease of serum albumin concentration (p<0.001). It was demonstrated that activity of the enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase significantly decreased (p< 0.001) in the group of undernourished rats treated with Acetaminophen compared with the other groups. We concluded that the Acetaminophen induces hepatic lesions in undernourished rats treated with a single non toxic dose of 100 mg/kg of weight, probably as a consequence of the inherent susceptibility to malnutrition.


REFERENCES

  1. Voishm W, Daly M, Boon A Healtley V. Paracetamol and acute billary pain wth cholestasis. Lancet. 1993;342:869.

  2. Roach J, Stacy B. Acetamnophen toxicity. Orthop Nurs 1997;16:49-53.

  3. Prescott LF, Wright N. The effect of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetics study. Br J Pharmacol 1973;49:602-613.

  4. Snawder J, Roe A, Wayne Benson R, Roberts D. Loss of CYP2E1 and CYPIA2 activity as a function of acetaminophen dose: Relation to toxicity. Biochem and Biophys Res Commun.1994;203:532-539

  5. Thatcher N, Edwards R, Lemone N, Dochmer J and Davies D. The potential of acetaminophen as a product in gene-directed enzyme proding therapy. Cancer gene Therapy. 2000;7:521-525.

  6. Allamed A, Vansoun E, Zarghi A. Role of glutation conjugation in protection of weanling rat liver against acetaminophen induced hepatotoxicity. Mech Ageing Dev 1997;95:71-79.

  7. Zimmermam HJ, Madddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 1995;22 767-773.

  8. Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose.QJM 2000;93:341-349.

  9. Hinson J, Han-Hsu H, Mays J, Holts S, Mc Lean P, Ketterrer B. Acetaminophen induced alteration in blood glucose and blood insulin levels in mice. Common Chem Pathol Pharmacol. 1984;43:381-391.

  10. Coles B, Wilson I, Wardman P, Hinson J, Nelson S, Keterer B. The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinoneimine with glutatione: a sloped flow kinetic study. Arch. Biochem Biophy 1988;264:253-260.

  11. Ugarte JM. Bases estadísticas de la investigación médica. Universidad de Chile. Santiago. 1958.

  12. Pofter V, Elvehjem CA. Modified method for study of the tissue oxidations. J.Biol.Chem.1936; 114:495-504.

  13. Tietz NW. Fundamentals of clinical chemistry. W B Saunders, Co. 1970

  14. Karmen A. Oxalacetate transaminase. J Clin lnvest 1955;34:131.

  15. Bowers GN, Mc Comb RB. Measurement of alkaline phosphatase activity in human serum. Clin Chem 1975;21:1988-1995.

  16. Bartholomew RJ, Delaney AM. Colorimetric determination of seric albumin. Proc Austral Assoc. Clin Bichem 1986;1:214.

  17. Fisher RA, Yates F. Tablas estadísticas para investigadores científicos. Madrid. 1949

  18. Campbel IRM, Kosterllitz HW. The effects on dietary protein on the tournover phospholipids ribonucleic acid and deoxy-ribonucleic acid in the liver. J. Biol. Chem 1984;175:989-990.

  19. Anthony LE, Edozien JC. Experimental protein and energy deficiencies in rat. J. Nutr 1975;105:631-648.

  20. Rosen F, Harding HR, Milholland RJ and Nichol CA. Glucocorticoids and transaminase activity. J Biol Chem 1963;238:3725-3729.

  21. Soberon G, Sanchez E. Changes in cifective enzyme concentration in growing rat liver. J Biol Chem 1961;236:1602-1605.

  22. Kwan D, Bartie W, Walker S. Abnormal serum transaminasas following therapeutic doses of acetaminophen in the absence of known risk factors. Digest. Disease and Sci 1995;40:1951-1955.

  23. Heubi J, Barbacci M, Zimmermam H. Therapeutic misadventures with acetaminophen: hepatoxicíty after multiple doses in children. J Pediatric 1998;132:22-27.

  24. Ross M, Ely J. Protein depletion and age. J. Franklin Inst. 1954;258:241-243.

  25. Miller L. Changes in rat liver enzyme activity with acute inanition. Relation of loses of enzyme activity to liver protein loss. J Bol Chem 1948;172:113-121.

  26. Segovia LT. Fosfatasa alcalina, proteína y ácidos nucleicos en hígado de ratas con restricción alimentaria aguda. Tesis de Ascenso. Universidad de Los Andes. Facultad de Medicina. Mérida Venezuela. 1982.

  27. Murherjee KL, Sarkar NK. Liver enzymes in human undernutrition. Brit J Nutr 1958;12:1.

  28. Prescoft LF. Paracetamol overdosage. Drug 1983;25:290-314.

  29. González-Mendoza M. Hepatotoxicidad del acetaminofén en ratas desnutridas. Tesis de Magíster Scientiarum. Universidad de Los Andes. Mérida Venezuela. 1991




2020     |     www.medigraphic.com